| 000 | 03782cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223032250.0 | ||
| 008 | 190423s2018 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.10.M.Sc.2018.Ah.R | ||
| 100 | 0 | _aAhmed Hesham Ezz Eldin Mohamed Mourad | |
| 245 | 1 | 2 |
_aA randomised controlled trial comparing topical glycerol versus narrow band ultraviolet light b in atopic dermatitis : _bA clinical and bacteriological evaluation / _cAhmed Hesham Ezz Eldin Mohamed Mourad ; Supervised Randa Mohamed Youssef , Vanessa Galal Hafez , Yasmine Elkholy |
| 246 | 1 | 5 |
_a{uFE97}{uFEA0}{uFEAE}{uFE91}{uFE94} {uFECB}{uFEB8}{uFEEE}ا{uئإ٨آ}{uئآئئ}{uئإ٩٤} {uئإإ٣}{uئإؤ٨}{uئإ٨إ}ر{uئإإ٧}{uئإ٩٤} {uئإ٩١}{uئآئئ}{uئإإ٦} ا{uئإؤئ}{uئإء٠}{uئإإ٠}{uئإآ٤}{uئإءإ}{uئآئإ}{uئإإ٦} ا{uئإؤئ}{uئإإ٤}{uئإإإ}ضعى و ا{uئإئ٧}{uئإآ٧}{uئإأأ}{uئإ٩٤} {uئإؤ٣}{uئإإإ}ق ا{uئإؤئ}{uئإ٩٢}{uئإإ٨}{uئإؤ٤}{uئإآ٤}{uئإء٠}{uئآئئ}{uئإ٩٤} ب {uئإآئ}{uئآئئ}{uئإؤ٨}{uئإ٩٤} ا{uئإؤئ}{uئإإ٨}{uئإأ٤}{uئإ٨إ}ق فى التهاب ا{uئإؤئ}ِ{uئإء٠}لد ا{uئإؤئ}{uئإ٩٨}{uئإ٨٤}َ{uئإ٩٧}بى : _b{uFE97}{uFED8}{uFBFF}{uFBFF}{uFEE2} {uFEB3}{uFEAE}{uFBFE}{uFEAE}ى و {uئإ٩ئ}{uئإءإ}ا{uئإ٩آ}ِيمى |
| 260 |
_aCairo : _bAhmed Hesham Ezz Eldin Mohamed Mourad , _c2018 |
||
| 300 |
_a136 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology | ||
| 520 | _aBackground: Atopic dermatitis (AD) is a chronic allergic disorder whose treatment is still a challenge. The staphylococcal skin load has been previously shown to aggravate AD. Narrow band ultraviolet B (NB-UVB) and glycerol in low concentration (20-40%) are established therapies for AD. Narrow band-UVB has been clinically proven to have antimicrobial actions and high concentration glycerol (85-100%) has been proven in vitro to have similar effects but hasn{u2019}t been clinically tested. Objectives: To evaluate the efficacy and tolerability of glycerol (85%) compared to NB-UVB in patients with atopic dermatitis, as assessed by clinical improvement and reduction of staphylococcal colonization of the skin. Patients and methods: 15 apparently healthy controls and 30 mild-moderate atopic dermatitis patients were enrolled in this study, recruited from Kasr Alainy dermatology outpatient clinic. Patients were randomly divided into 2 therapeutic groups: Group A (glycerol 85%): included 15 patients, each applied topical glycerol for 4 weeks. Group B (NB-UVB): included 15 patients. Every patient received 12 sessions of narrow band UVB (3 sessions per week) over 4 weeks. Swabs were taken from the skin and nose of both patients and controls to be cultured on selective media (mannitol-salt agar) for Staphylococci and quantified to determine colony forming units (CFU). Evaluation of response at end of therapy (4 weeks) was assessed using SCORAD and colony counts. Results: Both groups showed statistically insignificant microbial changes and statistically significant clinical improvement after treatment with no statistical difference between both groups | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAtopic dermatitis | |
| 653 | 4 | _aGlycerol | |
| 653 | 4 | _aNB-UVB | |
| 700 | 0 |
_aRanda Mohamed Youssef , _eSupervisor |
|
| 700 | 0 |
_aVanessa Galal Hafez , _eSupervisor |
|
| 700 | 0 |
_aYasmine Elkholy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c71652 _d71652 |
||